(IN BRIEF) A new study led by researchers at The Institute of Cancer Research, London, has identified a promising new combination therapy for pancreatic cancer that could transform future treatment. The dual approach — combining boiling histotripsy and oncolytic reovirus … Read the full press release
Posted in Business, Education, Healthcare, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged boiling histotripsy, cancer research, cancer treatment innovation, Gail ter Haar, ICR, ICR study identifies new immune-based combination strategy to improve pancreatic cancer treatment outcomes, immune response, immunotherapy, Institute of Cancer Research, macrophages, neutrophils, oncolytic reovirus, pancreatic cancer, Pancreatic cancer study from ICR highlights new dual treatment approach and reveals key immune cell insights, Pancreatic Cancer UK, Petros Mouratidis, Pharmaceutics, preclinical study, The Institute of Cancer Research identifies promising dual treatment strategy for pancreatic cancer, tumour microenvironment, ultrasound therapy, viral immunotherapy
(IN BRIEF) Researchers at Newcastle University have discovered a new biological mechanism explaining why some patients do not respond to immune checkpoint blockade (ICB) therapy for solid cancer tumors. They identified T regulatory cells (Tregs) as key drivers of ICB … Read the full press release
Posted in Business, Education, Financial, Healthcare, Industrial, Investment, Management, News, Science, Technology, United Kingdom
Tagged anti-CD30, Brentuximab Vedotin, Cancer Immunotherapy, cancer research, combination treatment, ICB resistance, immune checkpoint blockade, immunotherapy breakthroughs, lung cancer, melanoma, metastatic cancer, Newcastle University, pancreatic cancer, PD-1, skin cancer, solid tumors, T regulatory cells
(IN BRIEF) Researchers from the University of Copenhagen and Rigshospitalet have made significant strides in developing a new treatment for pancreatic cancer using antibody-drug conjugates (ADCs). This targeted therapy promises to improve survival rates by precisely attacking cancer cells while … Read the full press release
Posted in Business, Denmark, Education, Financial, Healthcare, Industrial, Investment, Management, News, Science, Technology
Tagged ADC, antibody-drug conjugates, cancer treatment, chemotherapy, colon cancer, Finsen Laboratory, human clinical trials, immune system, Lars Henning Engelholm, pancreatic cancer, pharmaceutical research, precision medicine, Rigshospitalet, sarcoma, Science Advances, survival rates, targeted therapy, triple-negative breast cancer, University of Copenhagen
(IN BRIEF) Researchers at Eindhoven University of Technology (TU/e) are developing AI-based solutions to improve the detection and treatment of pancreatic cancer, a highly deadly form of cancer. EngD candidate Victoria Bruno and PhD candidate Terese Hellström are collaborating with … Read the full press release
Posted in Artificial Intelligence (AI), Business, Education, Environment, Financial, Healthcare, Industrial, Investment, Management, Netherlands, News, Science, Technology
Tagged AI, Detection, pancreatic cancer, Terese Hellström, TU/e, Victoria Bruno
Why identical mutations cause different types of cancer Cancer development is influenced by tissue type (PRESS RELEASE) MUNICH, 20-Jul-2021 — /EuropaWire/ — Technical University of Munich (TUM), one of Europe’s leading universities, has announced that its Professor for Translational Cancer … Read the full press release
Posted in Education, Germany, Healthcare, News, Science, Technology
Tagged biliary tract cancer, Cancer, cancer drivers, cancerous diseases, Chiara Falcomatà, Dieter Saur, DKTK, extrahepatic bile duct cancer, Functional Genomics, Genes, German Cancer Consortium, Günter Schneider, human cancers, Klinikum rechts der Isar, KRAS, Molecular Oncology, oncogenes, organs, pancreatic cancer, PIK3CA, Roland Rad, Technical University of Munich, treatment of pancreatic cancer, treatments of cancerous diseases, TUM, University Medical Center Göttingen
Agreement aims to enable precision diagnostics for pancreatic cancer by developing new methods* to resolve single-cell level differences within and between tumors Memorial Sloan Kettering Cancer Center will use Philips IntelliSpace Genomics platform for advanced analytics and research collaboration capabilities … Read the full press release
University of Leicester Professor in study for early detection of disease 7-5-2013 — /europawire.eu/ — National charity Pancreatic Cancer UK has today announced the award of a £72,000 grant to Professor Jacqui Shaw and colleagues at the University of Leicester as … Read the full press release
Posted in Education, Financial, Healthcare, Non Profit, Science, Society, United Kingdom
Tagged Cancer, cancer research, charity, Dr Martins, Dr Neal, grant, grants, Jacqui Shaw, lethal disease, pancreatic cancer, pancreatic cancer research, Pancreatic Cancer UK, Professor Manson, UK, University of Leicester
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?